Association Between Hypermobility and Chronic Musculoskeletal Pain
Launched by AMRITA INSTITUTE OF MEDICAL SCIENCES & RESEARCH CENTER · Dec 15, 2009
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Completed their 25th birthday
- • 2. Not yet celebrated their 40th birthday
- • 3. Are relatives of patients being treated in Amrita Institute of Medical Sciences or voluntary blood donors in the same institute
- Exclusion Criteria:
- • 1. Subjects who have been diagnosed previously with a inflammatory musculoskeletal disease.
- • 2. Subjects detected to have signs or symptoms of inflammatory arthritis on a detailed clinical examination and history taking.
- • 3. Subjects who have symptoms suggestive of diabetes mellitus or hypothyroidism or have been previously diagnosed with the same.
- • 4. Subjects who are not willing to participate.
- • 5. Subjects who have been diagnosed as having a connective tissue disorder or have a family history of the same.
About Amrita Institute Of Medical Sciences & Research Center
Amrita Institute of Medical Sciences & Research Center is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Kochi, India, the institute combines state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among healthcare professionals and researchers. Committed to ethical practices and patient safety, Amrita Institute aims to contribute to the global medical community by developing new therapies and treatment modalities that address pressing health challenges. Through its robust clinical trial program, the institute seeks to enhance the understanding of various diseases and improve clinical outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kochi, Kerala, India
Patients applied
Trial Officials
Sharath Kumar, MD
Principal Investigator
Amrita Institute of Medical Sciences
L Rajam, MD
Study Director
Amrita Institute of Medical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials